SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1446179 BALA CYNWYD, PA

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$637,257

+$14,916 QoQ

Shares Held

37,663

-45.6% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#146

of 323 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $18,967,826 across 42 Biotechnology names. NTLA ranks #6 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	91,886	$5,257,716
2	NKTR	Nektar Therapeutics	20,177	$1,408,556
3	QURE	uniQure N.V.	15,042	$692,834
4	OLMA	Olema Pharmaceuticals, Inc.	55,121	$689,563
5	VKTX	Viking Therapeutics, Inc.	16,620	$648,346
6	NTLA	Intellia Therapeutics, Inc. This page	37,663	$637,257
7	HRMY	Harmony Biosciences Holdings, Inc.	17,322	$630,694
8	IMNM	Immunome Inc.	26,035	$551,681

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$637,257	37,663	-45.6%	Shares	Sole	2026-08-14
2025-12-31	$622,341	69,226	-55.7%	Shares	Sole	2026-02-17
2025-09-30	$2,697,643	156,204	0.0%	Shares	Sole	2025-11-14
2025-06-30	$1,465,193	156,204	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,110,610	156,204	+1155.9%	Shares	Sole	2025-05-14
2021-09-30	$1,668,557	12,438	-71.8%	Shares	Defined	2021-11-15
2021-06-30	$7,132,945	44,055	0.0%	Shares	Defined	2021-08-11
2021-03-31	$3,535,634	44,055	0.0%	Shares	Defined	2021-05-17
2020-12-31	$2,396,592	44,055	0.0%	Shares	Defined	2021-02-16
2020-09-30	$875,813	44,055	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.